Predictors of virological failure in HIV-1-infected patients switching to dolutegravir maintenance monotherapy-Reference-Cited by-同舟云学术

Predictors of virological failure in HIV-1-infected patients switching to dolutegravir maintenance monotherapy

Published:2018-09-30 Issue:1 Volume:20 Page:63-68
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Wijting IEA¹^ORCID,Rutsaert SL²,Rokx C¹,Burger DM³,Verbon A¹,van Kampen JJA⁴,Boucher CAB⁴,Rijnders BJA¹,Vandekerckhove L²

Affiliation:

1. Department of Internal Medicine; Infectious Diseases; Erasmus University Medical Center; Rotterdam The Netherlands

2. Department of Internal Medicine; HIV Cure Research Center; Ghent University; Ghent Belgium

3. Department of Pharmacy; Radboud University Medical Center; Nijmegen The Netherlands

4. Department of Viroscience; Erasmus University Medical Center; Rotterdam The Netherlands

Funder

Erasmus Universiteit Rotterdam

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hiv.12675/fullpdf

Reference20 articles.

1. Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study;Cahn;Lancet,2013

2. Brief report: dolutegravir plus abacavir/lamivudine for the treatment of HIV-1 infection in antiretroviral therapy-naive patients: week 96 and week 144 results from the SINGLE randomized clinical trial;Walmsley;J Acquir Immune Defic Syndr,2015

3. Once-daily dolutegravir is superior to once-daily darunavir/ritonavir in treatment-naïve HIV-1-positive individuals: 96 week results from FLAMINGO;Molina;J Int AIDS Soc,2014

4. Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority study;Raffi;Lancet Infect Dis,2013

5. Marcelin AG Grude M Charpentier C et al French national survey of resistance to integrase inhibitors shows high differences of resistance selection rate in case of virological failure in a context of routine hospital care (ANRS-AC11 virology network)

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unlocking the potential: exploring the impact of dolutegravir treatment on body mass index improvement in underweight adults with HIV in Malawi;BMC Public Health;2024-05-16

2. Prevalence of Emergent Dolutegravir Resistance Mutations in People Living with HIV: A Rapid Scoping Review;Viruses;2024-03-04

3. Risk of Emergent Dolutegravir Resistance Mutations In People Living With HIV: A Rapid Scoping Review;2024-01-07

4. Dolutegravir Monotherapy Possibly Boosted by Highly Active Natural Immunity;Clinical Infectious Diseases;2023-06-20

5. Risk of Cardiovascular Diseases or Mortality in People With Higher Values of HIV-1 DNA;JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-06-01